Login to Your Account

30th Annual J.P. Morgan Healthcare Conferenc

China Seeks Biotech Stardom: Cash Aplenty, Innovation Needed

By Jennifer Boggs
Managing Editor

Friday, January 13, 2012

SAN FRANCISCO – The global recession left the U.S. and much of the rest of the world strapped for cash, with both harsh venture and capital markets taking their toll on the biotech sector. But in China, the economic situation is "really kind of the reverse," noted Greg Scott, founder and president of ChinaBio LLC.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription